BioNTech SE Income Statement (2018-2025) | BNTX

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
2.47B6.39B7.18B6.33B7.15B3.41B3.49B4.36B1.37B0.18B0.97B1.59B0.20B0.14B0.07B3,526.36B0.02B0.01B1.78B0.04B
Cost of Revenue (Quarter)
0.28B1.06B1.43B0.67B1.45B0.82B0.76B0.19B0.10B0.18B0.18B0.19B0.06B0.06B0.20B0.26B0.09B0.09B0.17B0.39B
Gross Profit (Quarter)
2.19B5.33B5.75B5.66B5.70B2.59B2.73B4.18B1.27B0.01B0.80B1.40B0.14B0.07B-0.13B3,526.10B-0.06B-0.08B1.60B-0.34B
Operating items
Research & Development (Quarter)
-0.26B-0.24B-0.31B-0.31B-0.32B-0.43B-0.34B-0.52B-0.36B-0.41B-0.54B-0.62B-0.55B-0.63B-0.60B-0.65B-0.55B-0.58B-0.66B-0.59B
Share-based Compensation (IS) (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.05B-0.78B-0.03B-0.00B-0.01B-0.00B-0.01B-0.15B-0.01B-0.00B-0.01B-0.00B-0.01B
Selling, General & Administrative (Quarter)
-0.05B-0.06B-0.08B-0.15B-0.10B-0.14B-0.14B-0.12B-0.12B-0.13B-0.15B-0.13B-0.13B-0.18B-0.15B-0.12B-0.11B-0.13B-0.14B-0.20B
Operating Expenses (Quarter)
-0.31B-0.30B-0.39B-0.46B-0.42B-0.57B-0.49B-0.64B-0.48B-0.54B-0.69B-0.76B-0.68B-0.81B-0.75B-0.77B-0.67B-0.71B-0.80B-0.78B
Operating Income (Quarter)
2.01B5.06B5.57B5.38B5.33B2.36B2.41B3.36B0.70B-0.61B0.08B0.57B-0.55B-1.04B0.01B0.16B-0.56B-0.57B-0.05B-0.38B
EBIT (Quarter)
2.01B5.06B5.57B5.38B5.33B2.36B2.41B3.36B0.70B-0.61B0.08B0.57B-0.55B-1.04B0.01B0.16B-0.56B-0.57B-0.05B-0.38B
Non-operating items
Interest & Investment Income (Quarter)
0.03B-0.00B-0.00B0.02B0.31B0.12B0.06B0.04B0.09B0.17B0.17B0.17B0.20B0.18B0.17B0.18B0.13B0.12B0.11B0.12B
Other Non Operating Income (Quarter)
-0.00B-0.00B0.00B0.02B0.01B-0.01B-0.03B-0.07B
Net income details
EBT (Quarter)
0.00B4.84B5.50B5.39B5.63B2.47B2.46B3.24B0.76B-0.45B0.25B0.71B-0.36B-0.87B0.17B0.32B-0.47B-0.46B0.03B-0.26B
Tax Provisions (Quarter)
-0.62B1.49B3.78B1.77B1.48B-0.69B0.66B-0.91B-0.22B-0.24B-0.07B0.22B0.02B0.00B0.04B0.04B-0.03B0.02B0.06B0.09B
Profit After Tax (Quarter)
0.00B3.36B3.79B3.62B4.15B1.78B1.80B2.32B0.54B-0.21B0.17B0.49B-0.34B-0.87B0.22B0.28B-0.44B-0.44B-0.03B-0.36B
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
0.62B3.36B1.72B3.62B4.15B3.17B1.80B4.15B0.98B-0.21B0.32B0.49B-0.38B-0.87B0.13B0.28B-0.44B-0.47B-0.03B-0.36B
Consolidated Net Income (Quarter)
0.62B3.36B1.72B3.62B4.15B3.17B1.80B4.15B0.98B-0.21B0.32B0.49B-0.38B-0.87B0.13B0.28B-0.44B-0.47B-0.03B-0.36B
Income towards Parent Company (Quarter)
0.62B3.36B1.72B0.00B4.15B3.17B1.80B4.15B0.98B-0.21B0.32B0.49B-0.38B-0.87B0.13B0.28B-0.44B-0.47B-0.03B-0.36B
Net Income towards Common Stockholders (Quarter)
0.62B3.36B1.72B0.00B4.15B3.17B1.80B4.15B0.98B-0.21B0.32B0.49B-0.38B-0.87B0.13B0.28B-0.44B-0.47B-0.03B-0.36B
Additional items
EPS (Basic) (Quarter)
0.0016.713.67-0.770.00B1.90-1.40-3.250.00B0.00B-1.67-1.68-0.12-1.18
EPS (Weighted Average and Diluted) (Quarter)
0.00B0.00B0.00B0.00B
Shares Outstanding (Weighted Average) (Quarter)
0.28B0.25B0.27B0.27B0.00B0.26B0.27B0.27B900.540.00B0.26B0.28B0.29B0.30B
Shares Outstanding (Diluted Average) (Quarter)
0.00B0.00B889.560.00B
EBITDA (Quarter)
2.01B5.06B5.57B5.38B5.33B2.36B2.41B3.36B0.70B-0.61B0.17B0.57B-0.32B-0.99B0.21B0.16B-0.50B-0.48B-0.05B-0.38B
Interest Expenses (Quarter)
-0.05B0.21B-0.10B-0.00B-0.01B-0.01B-0.00B-0.16B-0.03B-0.00B-0.00B-0.03B-0.01B-0.01B-0.01B-0.01B-0.04B-0.01B-0.03B-0.00B
Tax Rate (Quarter)
-31,309,748.52%30.71%68.69%32.83%26.29%-27.91%26.97%-28.18%-29.04%53.81%-29.38%30.96%-5.03%-0.25%24.83%13.84%6.65%-4.00%216.19%-34.12%